[go: up one dir, main page]

FR2978918B1 - Solution injectable a ph7 comprenant au moins une insuline basale dont le pi est compris entre 5,8 et 8,5 - Google Patents

Solution injectable a ph7 comprenant au moins une insuline basale dont le pi est compris entre 5,8 et 8,5

Info

Publication number
FR2978918B1
FR2978918B1 FR1157291A FR1157291A FR2978918B1 FR 2978918 B1 FR2978918 B1 FR 2978918B1 FR 1157291 A FR1157291 A FR 1157291A FR 1157291 A FR1157291 A FR 1157291A FR 2978918 B1 FR2978918 B1 FR 2978918B1
Authority
FR
France
Prior art keywords
injectable solution
basal insulin
basal
insulin
injectable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1157291A
Other languages
English (en)
Other versions
FR2978918A1 (fr
Inventor
Gerard Soula
Olivier Soula
Jeff Tonnar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Adocia SAS
Original Assignee
Adocia SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR1157291A priority Critical patent/FR2978918B1/fr
Application filed by Adocia SAS filed Critical Adocia SAS
Priority to RU2014108829/15A priority patent/RU2578460C2/ru
Priority to AU2012293463A priority patent/AU2012293463B2/en
Priority to EP16162474.7A priority patent/EP3053590A1/fr
Priority to DK12758562.8T priority patent/DK2741765T3/en
Priority to CA2843586A priority patent/CA2843586A1/fr
Priority to KR1020147005655A priority patent/KR101810055B1/ko
Priority to MX2014001190A priority patent/MX2014001190A/es
Priority to JP2014524435A priority patent/JP5950477B2/ja
Priority to US13/571,026 priority patent/US9089476B2/en
Priority to BR112014002986A priority patent/BR112014002986A2/pt
Priority to CN201280038926.9A priority patent/CN103889442B/zh
Priority to EP12758562.8A priority patent/EP2741765B9/fr
Priority to PCT/FR2012/051880 priority patent/WO2013021143A1/fr
Publication of FR2978918A1 publication Critical patent/FR2978918A1/fr
Application granted granted Critical
Publication of FR2978918B1 publication Critical patent/FR2978918B1/fr
Priority to IL230611A priority patent/IL230611A/en
Priority to ZA2014/00773A priority patent/ZA201400773B/en
Priority to US14/721,889 priority patent/US20170182131A9/en
Priority to US16/025,832 priority patent/US20180311316A1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR1157291A 2011-08-10 2011-08-10 Solution injectable a ph7 comprenant au moins une insuline basale dont le pi est compris entre 5,8 et 8,5 Expired - Fee Related FR2978918B1 (fr)

Priority Applications (18)

Application Number Priority Date Filing Date Title
FR1157291A FR2978918B1 (fr) 2011-08-10 2011-08-10 Solution injectable a ph7 comprenant au moins une insuline basale dont le pi est compris entre 5,8 et 8,5
CN201280038926.9A CN103889442B (zh) 2011-08-10 2012-08-09 至少一种基础胰岛素的可注射溶液
EP16162474.7A EP3053590A1 (fr) 2011-08-10 2012-08-09 Solution injectable d'au moins une insuline basale
DK12758562.8T DK2741765T3 (en) 2011-08-10 2012-08-09 Injectable solution of at least one type of basal insulin
CA2843586A CA2843586A1 (fr) 2011-08-10 2012-08-09 Solution injectable d'au moins une insuline basale
KR1020147005655A KR101810055B1 (ko) 2011-08-10 2012-08-09 하나 이상의 유형의 기저 인슐린의 주사액
MX2014001190A MX2014001190A (es) 2011-08-10 2012-08-09 Solucion inyectable de al menos insulina basal.
JP2014524435A JP5950477B2 (ja) 2011-08-10 2012-08-09 少なくとも１種の基礎インスリンの注射溶液
US13/571,026 US9089476B2 (en) 2011-08-10 2012-08-09 Injectable solution at pH 7 comprising at least one basal insulin whose PI is between 5.8 and 8.5
PCT/FR2012/051880 WO2013021143A1 (fr) 2011-08-10 2012-08-09 Solution injectable d'au moins une insuline basale
RU2014108829/15A RU2578460C2 (ru) 2011-08-10 2012-08-09 Приемлемый для инъекций раствор по меньшей мере одного базального инсулина
AU2012293463A AU2012293463B2 (en) 2011-08-10 2012-08-09 Injectable solution of at least one type of basal insulin
BR112014002986A BR112014002986A2 (pt) 2011-08-10 2012-08-09 composição sob a forma de uma solução injetável, e formulação de dose única
EP12758562.8A EP2741765B9 (fr) 2011-08-10 2012-08-09 Solution injectable d'au moins une insuline basale
IL230611A IL230611A (en) 2011-08-10 2014-01-23 A solution for injecting at least one type of basic insulin
ZA2014/00773A ZA201400773B (en) 2011-08-10 2014-01-31 Injectable solution of at least one type of basal insulin
US14/721,889 US20170182131A9 (en) 2011-08-10 2015-05-26 Injectable solution at ph 7 comprising at least one basal insulin whose pi is between 5.8 and 8.5
US16/025,832 US20180311316A1 (en) 2011-08-10 2018-07-02 Injectable solution at ph 7 comprising at least one basal insulin whose pi is between 5.8 and 8.5

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1157291A FR2978918B1 (fr) 2011-08-10 2011-08-10 Solution injectable a ph7 comprenant au moins une insuline basale dont le pi est compris entre 5,8 et 8,5

Publications (2)

Publication Number Publication Date
FR2978918A1 FR2978918A1 (fr) 2013-02-15
FR2978918B1 true FR2978918B1 (fr) 2013-12-27

Family

ID=45463750

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1157291A Expired - Fee Related FR2978918B1 (fr) 2011-08-10 2011-08-10 Solution injectable a ph7 comprenant au moins une insuline basale dont le pi est compris entre 5,8 et 8,5

Country Status (1)

Country Link
FR (1) FR2978918B1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016001862A1 (fr) * 2014-07-04 2016-01-07 Wockhardt Limited Formulations à libération prolongée d'insulines
EP3419649B1 (fr) * 2016-02-25 2025-04-09 Wockhardt Limited Compositions pharmaceutiques stables comprenant de l'insuline glargine et de l' insuline aspart et procédés de préparation de celles-ci

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009532552A (ja) * 2006-04-07 2009-09-10 アドシア 二官能化された多糖類
JP2009533471A (ja) * 2006-04-12 2009-09-17 バイオデル， インコーポレイテッド 即効型および長時間作用型組合せインスリン製剤
FR2940802A1 (fr) * 2008-10-10 2010-07-09 Adocia Complexe entre l'insuline humaine et un polymere amphiphile et utilisation de ce complexe pour la preparation d'une formulation d'insuline humaine rapide.
FR2943538B1 (fr) * 2009-03-27 2011-05-20 Adocia Formulation a action rapide d'insuline recombinante humaine
FR2958646B1 (fr) * 2010-04-07 2012-05-18 Adocia Polysaccharides comportant des groupes fonctionnels carboxyles substitues par un derive d'acide hydrophobe.
CN102834117B (zh) * 2010-02-09 2015-11-25 阿道恰公司 通过至少两个由至少三价的间隔物所携带的疏水基团进行官能化的阴离子多糖

Also Published As

Publication number Publication date
FR2978918A1 (fr) 2013-02-15

Similar Documents

Publication Publication Date Title
FR2985428B1 (fr) Solution injectable a ph 7 comprenant au moins une insuline basale dont le pi est compris entre 5,8 et 8,5 et un polyaminoacide substitue
FR2985429B1 (fr) Solution injectable a ph 7 comprenant au moins une insuline basale dont le pi est compris entre 5,8 et 8,5 et un polyaminoacide substitue obtenu par un procede de polymerisation controle
EP2668586A4 (fr) Approvisionnement selon l'état d'un client comprenant une image intégrée basée sur windows
IT1398142B1 (it) Sistema singolo con compressore e pompa integrati e metodo.
CY1118616T1 (el) Λιξισενατιδη ως προσθετη θεραπεια σε βασικη ινσουλινη σε διαβητη τυπου 2
EP2663609A4 (fr) Composé pour dispositif optoélectronique organique, diode électroluminescente organique le comprenant et afficheur comprenant la diode électroluminescente organique
EP2877157A4 (fr) Formulation liquide à base d'un conjugué d'insuline à action prolongée
EP2786410A4 (fr) Dispositif de puits quantique à électrodes latérales
EP3030891A4 (fr) Biocapteur à nanotube de carbone simple paroi (swcnt) destiné à détecter du glucose, du lactate et de l'urée
JP2013541099A5 (fr)
WO2011094439A3 (fr) Appareil d'attache de dispositif électronique portable
FR3001607B1 (fr) Semoir monograine avec au moins un element semeur perfectionne
WO2013019646A3 (fr) Fils électriques pour traversée murale
BR112015026191A2 (pt) barra de reforço, conjunto de conduto de fluxo, e, método para montar um medidor de fluxo vibratório.
FR3002293B1 (fr) Pompe a precompression amelioree.
EP2725633A4 (fr) Polymère destiné à être utilisé dans un élément électroluminescent organique et élément électroluminescent organique employant le polymère
IT1403377B1 (it) Braccio oscillante trasversale con perno di banco e procedimento per la fabbricazione di un braccio oscillante trasversale.
IN2013MU03124A (fr)
WO2013079675A3 (fr) Dispositif de positionnement et de fixation d'un element d'affichage et dispositif d'affichage
FR2978918B1 (fr) Solution injectable a ph7 comprenant au moins une insuline basale dont le pi est compris entre 5,8 et 8,5
JP2015521279A5 (fr)
BR112014007758A2 (pt) composto à base de fenilisoxazolina orto-substituído, com 2,6-difluorobenziloximetil, método e uso do mesmo
EP2815199A4 (fr) Récipient de contrepoids destiné à être utilisé dans une arme sans recul et arme sans recul comprenant un tel récipient de contrepoids
EP2877200A4 (fr) Analogues de l'insuline modifiés par un glucide relié à l'oxygène
MX349936B (es) Paneles de acceso.

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 6

ST Notification of lapse

Effective date: 20180430